0PQ Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ProQR Therapeutics NV

Watchlist Manager

Watchlist

Price: 1.812 EUR 1.34% Market Closed

Market Cap: €148m

	ProQR Therapeutics NV F:0PQ	NL
	Grupo Aeroportuario del Pacifico SAB de CV OTC:GPAEF	MX
P	Polytec Holding AG XMUN:P4N	AT
	Perrigo Company PLC F:PIG	IE
V	Verisign Inc XMUN:VRS	US
K	Kuehne und Nagel International AG F:KNIA	CH
H	Heriot REIT Ltd JSE:HET	ZA
A	Air China Ltd XMUN:AD2	CN
W	Willis Towers Watson PLC F:WTY	UK
M	Mitsui Fudosan Co Ltd XMUN:MFU	JP
A	Accenture PLC XMUN:CSA	IE

Profitability Summary

ProQR Therapeutics NV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-233%

Negative 3Y Average Operating Margin

-277%

Operating Margin is Increasing

-1 217% > -233%

Negative Net Margin

-228%

Negative 3Y Average Net Margin

-256%

Net Margin is Increasing

-1 247% > -228%

Negative Free Cash Flow Margin

-272%

Negative 3Y Average Free Cash Flow Margin

-181%

Declining Free Cash Flow Margin

13% > -272%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-184%

Declining ROIC

-245% > -261%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.